Company Overview of Histogen, Inc.
Histogen, Inc., a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. The company focuses on the research, development, and manufacturing of products derived from its technology. It offers an insoluble human extracellular matrix (hECM); and a soluble complex of proteins. The company’s technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. It has joint venture with PUR Biologics, Adaptive Biologix, and Histogen Aesthetics to develop additional products. Histogen, Inc. was founded in 2007 and is based in San Di...
10655 Sorrento Valley Road
San Diego, CA 92121
Founded in 2007
Key Executives for Histogen, Inc.
Founder, Chairman and Chief Executive Officer
Director of Corporate Communications
Director of Clinical Affairs
Director of Applied Research
Compensation as of Fiscal Year 2016.
Histogen, Inc. Key Developments
Histogen, Inc. Announces License Agreement with Pineworld Capital, Ltd., for Development and Commercialization of its Proprietary Hair Stimulating Complex (HSC) in Mainland China
Sep 27 16
Histogen, Inc. announced a license agreement with Pineworld Capital Ltd., for the development and commercialization of its proprietary Hair Stimulating Complex (HSC) in Mainland China. Through an exclusive license and supply agreement, Pineworld will focus on clinical development, registration, marketing and sales of the HSC injectable hair growth treatment in China. Under the terms of the license, Histogen will receive the payments, a transfer price on the product, and escalating royalties on future sales. Histogen will utilize its patented technology process to manufacture HSC for the China market.
Histogen to Enter into Licensing Agreement with Huapont Life Sciences
Aug 17 16
Histogen, Inc. and Huapont Life Sciences Co., Ltd. are planning to enter into a license and supply agreement for the development and commercialization of hair stimulating complex (HSC) product in Mainland China. Histogen is a US-based regenerative medicine company that develops solutions based on the products of cells grown under simulated embryonic conditions, while Huapont Life Sciences is a China-based pharmaceutical company.
Histogen, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Dec 18 14
Histogen, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 10, 2016